These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 21757451

  • 1. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
    Cullen G, Bader C, Korzenik JR, Sands BE.
    Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
    [Abstract] [Full Text] [Related]

  • 2. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN.
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [Abstract] [Full Text] [Related]

  • 3. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 4. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec 27; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
    Launay O, Abitbol V, Krivine A, Slama LB, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F, MICIVAX Study Group.
    J Crohns Colitis; 2015 Dec 27; 9(12):1096-107. PubMed ID: 26351392
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.
    Vaccine; 2012 Feb 01; 30(6):1108-14. PubMed ID: 22178515
    [Abstract] [Full Text] [Related]

  • 7. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.
    Le Corre N, Thibault F, Pouteil Noble C, Meiffrédy V, Daoud S, Cahen R, Charreau I, Bottigioli D, Dollinger C, Aboulker JP, Autran B, Morelon E, Barrou B.
    Vaccine; 2012 Dec 14; 30(52):7522-8. PubMed ID: 23103195
    [Abstract] [Full Text] [Related]

  • 8. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H, Wenisch JM, Tobudic S, Gualdoni GA, Rödler S, Rasoul-Rockenschaub S, Jaksch P, Redlberger-Fritz M, Popow-Kraupp T, Burgmann H.
    Vaccine; 2011 Sep 16; 29(40):6888-93. PubMed ID: 21803100
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.
    Rheumatology (Oxford); 2012 Apr 16; 51(4):695-700. PubMed ID: 22171015
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
    Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong DB, Wechsler B, Hervier B, Miyara M, Morel N, Le Corre N, Arnaud L, Piette JC, Musset L, Autran B, Rozenberg F, Amoura Z.
    Arthritis Rheum; 2011 Nov 16; 63(11):3502-11. PubMed ID: 21811996
    [Abstract] [Full Text] [Related]

  • 11. Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation.
    Lagler H, Tobudic S, Ramharter M, Elandt K, Sperr WR, Redlberger-Fritz M, Popow-Kraupp T, Jäger U, Zielinski CC, Burgmann H.
    Vaccine; 2012 Nov 06; 30(48):6864-70. PubMed ID: 22989690
    [Abstract] [Full Text] [Related]

  • 12. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.
    HIV Med; 2012 Jul 06; 13(6):352-7. PubMed ID: 22296264
    [Abstract] [Full Text] [Related]

  • 13. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.
    Fairhead T, Hendren E, Tinckam K, Rose C, Sherlock CH, Shi L, Crowcroft NS, Gubbay JB, Landsberg D, Knoll G, Gill J, Kumar D.
    Transpl Infect Dis; 2012 Dec 06; 14(6):575-83. PubMed ID: 22999005
    [Abstract] [Full Text] [Related]

  • 14. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul 06; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

  • 15. Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability.
    Hara M, Hanaoka T, Mizushima T, Honma J, Maeda K, Ohfuji S, Tanaka K, Hirota Y.
    Vaccine; 2011 Oct 26; 29(46):8323-9. PubMed ID: 21893146
    [Abstract] [Full Text] [Related]

  • 16. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR.
    Vaccine; 2011 Nov 15; 29(49):9209-13. PubMed ID: 21974995
    [Abstract] [Full Text] [Related]

  • 17. Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies.
    Mariotti J, Spina F, Carniti C, Anselmi G, Lucini D, Vendramin A, Pregliasco F, Corradini P.
    Eur J Haematol; 2012 Aug 15; 89(2):111-9. PubMed ID: 22540245
    [Abstract] [Full Text] [Related]

  • 18. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct 15; 25(5):351-4. PubMed ID: 22338222
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 15; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 20. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.
    Rahier JF, Papay P, Salleron J, Sebastian S, Marzo M, Peyrin-Biroulet L, Garcia-Sanchez V, Fries W, van Asseldonk DP, Farkas K, de Boer NK, Sipponen T, Ellul P, Louis E, Peake ST, Kopylov U, Maul J, Makhoul B, Fiorino G, Yazdanpanah Y, Chaparro M, European Crohn's and Colitis Organisation (ECCO).
    Gut; 2011 Apr 15; 60(4):456-62. PubMed ID: 21270121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.